RecruitingPhase 4NCT06852391

JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesity

Studying Disorder of energy metabolism

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
McMaster University
Principal Investigator
Katherine M Morrison, MD FRCPC
McMaster University
Intervention
Semaglutide Pen Injector(drug)
Enrollment
74 target
Eligibility
12-17 years · All sexes
Timeline
20252027

Study locations (1)

Collaborators

Canadian Institutes of Health Research (CIHR) · Diabetes Canada

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06852391 on ClinicalTrials.gov

Other trials for Disorder of energy metabolism

Additional recruiting or active studies for the same condition.

See all trials for Disorder of energy metabolism

← Back to all trials